Assesment Of Hpv Dna Positive Individuals In Sivas Province In Terms Of Some Variables
Abstract
Methods: The study was conducted on 215 women who were directed to Sivas Cumhuriyet University Obstetry and Gynecology outpatient clinic by her gynecologists or family physicians between 2015-2018 years. A questionnary containing datas of patients about age, education levels and jobs of both spouses, smoking status, obstetric history and age of first sexual intercourse was filled out by the researcher. The data were analysed with SPSS (vers 23.0) program and significance level was taken as 0.05.
Results: The most prevalent HPV types were type 16 and category of the others; with the rates of respectively 47% (n: 101), 40% (n: 86). The frequencies of ASCUS (undetermined atypical squamous epithelial cells), LGSIL (low-grade squamous intraepithelial lesion) and HGSIL (high-grade squamous intraepithelial lesion) were respectively found to be 7.9% (n: 17), 23.7% (n: 51) and 1.9% (n: 4). The relationship between HPV types and Pap Smear results was statistically significant (p: 0.011). There was no difference between patients and their spouses about education levels and occupations; and among patients on smoking status, menstrual patterns, age at first sexual intercourse and family planning methods and HPV types (p> 0.05). In women above aged 55, only two types of HPV DNA were observed; which were type 16 and category of the others (p: 0.005). The relationship between abortion history and HPV types was found out to be significant (p: 0.016).
Conclusion: This study has contributed to the literature by revealing the types of HPV which observed in Sivas province over a period of 3 years.
Keywords
Kaynakça
- 1. WHO: International Agency for Research on Cancer. Cervical cancer: Estimated incidence, mortality and prevalence worldwide in 2012. In: The GLOBOCAN 2012 Database. Lyon, France: International Agency for Research on Cancer.
- 2. Okunade KS. Human Papillomavirus and Cervical Cancer. Current Perspectives in Human Papillomavirus. Shailendra K. Saxena, IntechOpen, DOI: 10.5772/intechopen.81581.
- 3. Burd EM. Human papillomavirus and cervical cancer. Clinical Microbiology Reviews. 2003;16(1):1-17.
- 4. Koliopoulos G, Arbyn M, Martin-Hirsch P, Kyrgiou M, Prendiville W, Paraskevaidis E. Diagnostic accuracy of human papillomavirus testing in primary cervical screening: A systematic review and meta-analysis of non-randomized studies. Gynecol Oncol, 2007;104: 232-46.
- 5. Cervical Cancer Prevention and Early Detection. The American Cancer Society (AAC). https://www.cancer.org/cancer/cervical-cancer/prevention-and-early-detection/hpv-test.html 6. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. The Journal of Pathology. 1999;189:12-19.
- 7. Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV, et al. Epidemiologic classification of human papillomavirustypes associated with cervical cancer. N Engl J Med, 2003;348:518-27.
- 8. de Sanjose S, Quint WG, Alemany L, Geraets DT, Klaustermeier JE, Lloveras B, et al. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol, 2010;11(11):1048-56.
- 9. Kan Ö, Görkem Ü, Barış A, Koçak Ö, Toğrul C, Yıldırım E. Kanser erken teşhis ve tarama eğitim merkezleri (KETEM)’ne başvuran kadınlarda human papillomavirüs (HPV) sıklığının değerlendirilmesi ve genotiplerin analizi. Turk Hij Den Biyol Derg, 2019;76(2):163-68.
Ayrıntılar
Birincil Dil
İngilizce
Konular
Sağlık Kurumları Yönetimi
Bölüm
Araştırma Makalesi
Yazarlar
Çağlar Yıldız
*
0000-0003-3150-3340
Türkiye
Yayımlanma Tarihi
1 Ekim 2022
Gönderilme Tarihi
17 Eylül 2022
Kabul Tarihi
28 Eylül 2022
Yayımlandığı Sayı
Yıl 2022 Cilt: 44 Sayı: 3